Company intelligence / Profile preview
Genechem
Shanghai, Shanghai, Chinagcbio.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Genechem is a leading biotechnology company based in Shanghai that focuses on novel drug target discovery and the development of cell therapies and antibodies. The company leverages its proprietary Good Research Practice (GRP) platform, which integrates a large network of research hospitals and advanced genetic tools, to translate clinical research into oncology therapeutics. Genechem has several CAR-T programs in Phase 2 clinical trials, including treatments for liver cancer and lymphoma.
- Therapeutic areas
- OncologyImmunology
- Modalities
- CAR-T cell therapyT cell receptor engineered T cell therapyMonoclonal antibodyBispecific monoclonal antibodyGene therapyCell therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
I-Mab BiopharmaXijing Hospital
Beyond the preview
Go deeper on Genechem.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genechem.